PAI
DGX icon

Pittenger & Anderson Inc’s Quest Diagnostics DGX Stock Holding History

Pittenger & Anderson Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.3K Hold
110
– – ﹤0.01% 358
2026
Q1 		$21.6K Hold
110
– – ﹤0.01% 361
2025
Q4 		$19.1K Hold
110
– – ﹤0.01% 365
2025
Q3 		$21K Hold
110
– – ﹤0.01% 342
2025
Q2 		$19.8K Hold
110
– – ﹤0.01% 330
2025
Q1 		$18.6K Hold
110
– – ﹤0.01% 330
2024
Q4 		$16.6K Hold
110
– – ﹤0.01% 340
2024
Q3 		$17.1K Hold
110
– – ﹤0.01% 348
2024
Q2 		$15.1K Hold
110
– – ﹤0.01% 352
2024
Q1 		$14.6K Hold
110
– – ﹤0.01% 350
2023
Q4 		$15.2K Hold
110
– – ﹤0.01% 342
2023
Q3 		$13.4K Hold
110
– – ﹤0.01% 329
2023
Q2 		$15.5K Hold
110
– – ﹤0.01% 333
2023
Q1 		$15.6K Hold
110
– – ﹤0.01% 327
2022
Q4 		$17.2K Hold
110
– – ﹤0.01% 320
2022
Q3 		$13K Hold
110
– – ﹤0.01% 333
2022
Q2 		$15K Hold
110
– – ﹤0.01% 328
2022
Q1 		$15K Hold
110
– – ﹤0.01% 333
2021
Q4 		$19K Hold
110
– – ﹤0.01% 313
2021
Q3 		$16K Hold
110
– – ﹤0.01% 337
2021
Q2 		$15K Hold
110
– – ﹤0.01% 313
2021
Q1 		$14K Hold
110
– – ﹤0.01% 307
2020
Q4 		$13K Hold
110
– – ﹤0.01% 305
2020
Q3 		$13K Hold
110
– – ﹤0.01% 295
2020
Q2 		$13K Buy
+110
New +$11.7K ﹤0.01% 291

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Pittenger & Anderson Inc's DGX Position: Q2 2026 in Review

Pittenger & Anderson Inc held its Quest Diagnostics (DGX) position steady in Q2 2026 at 110 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #358.

Pittenger & Anderson Inc first reported a position in DGX in Q2 2020 and has held it in 25 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Pittenger & Anderson Inc held 110 shares of Quest Diagnostics worth $23.3K as of Q2 2026.
  • Pittenger & Anderson Inc left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #358 holding.
  • Pittenger & Anderson Inc first reported a position in Quest Diagnostics in Q2 2020 and has held it in 25 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.